110 related articles for article (PubMed ID: 2473032)
1. Activation of substance P receptors leads to membrane potential responses in cultured astrocytes.
Wienrich M; Kettenmann H
Glia; 1989; 2(3):155-60. PubMed ID: 2473032
[TBL] [Abstract][Full Text] [Related]
2. Effects of receptor-selective neurokinin agonists and a neurokinin antagonist on the electrical activity of spinal cord neurones in culture.
Wienrich M; Reuss K; Harting J
Br J Pharmacol; 1989 Nov; 98(3):914-20. PubMed ID: 2480170
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
Keeler JR; Charlton CG; Helke CJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
[TBL] [Abstract][Full Text] [Related]
4. Selective agonists for receptors of substance P and related neurokinins.
Regoli D; Dion S; Rhaleb NE; Rouissi N; Tousignant C; Jukic D; D'Orleans-Juste P; Drapeau G
Biopolymers; 1989 Jan; 28(1):81-90. PubMed ID: 2470440
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of a substance P receptor antagonist: studies on peripheral and central nervous system hemodynamics and on specificity of action.
Helke CJ; Phillips ET; O'Neill JT
J Pharmacol Exp Ther; 1987 Jul; 242(1):131-6. PubMed ID: 2441024
[TBL] [Abstract][Full Text] [Related]
6. Substance P induces inward current and regulates pacemaker currents through tachykinin NK1 receptor in cultured interstitial cells of Cajal of murine small intestine.
Jun JY; Choi S; Yeum CH; Chang IY; You HJ; Park CK; Kim MY; Kong ID; Kim MJ; Lee KP; So I; Kim KW
Eur J Pharmacol; 2004 Jul; 495(1):35-42. PubMed ID: 15219818
[TBL] [Abstract][Full Text] [Related]
7. Effects of tachykinins on myenteric neurones of the guinea-pig gastric corpus: involvement of NK-3 receptors.
Schemann M; Kayser H
Pflugers Arch; 1991 Dec; 419(6):566-71. PubMed ID: 1724075
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of the glutamate receptor in cultured astrocytes.
Backus KH; Kettenmann H; Schachner M
J Neurosci Res; 1989 Mar; 22(3):274-82. PubMed ID: 2540340
[TBL] [Abstract][Full Text] [Related]
9. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
Sagan S; Chassaing G; Pradier L; Lavielle S
J Pharmacol Exp Ther; 1996 Mar; 276(3):1039-48. PubMed ID: 8786533
[TBL] [Abstract][Full Text] [Related]
10. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
11. Mediation of irregular spiking activity by multiple neurokinin-receptors in the small intestine of the rat.
Lördal M; Bränström R; Hellström PM
Br J Pharmacol; 1998 Jan; 123(1):63-70. PubMed ID: 9484855
[TBL] [Abstract][Full Text] [Related]
12. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries.
Miike T; Shirahase H; Kanda M; Kunishiro K; Kurahashi K
Vascul Pharmacol; 2009; 51(2-3):147-53. PubMed ID: 19539781
[TBL] [Abstract][Full Text] [Related]
13. Glutamate receptor-linked changes in membrane potential and intracellular Ca2+ in primary rat astrocytes.
Enkvist MO; Holopainen I; Akerman KE
Glia; 1989; 2(6):397-402. PubMed ID: 2574162
[TBL] [Abstract][Full Text] [Related]
14. Substance P modulation of the membrane potential of the Schwann cell of the squid giant nerve fibre.
Evans PD; Reale V; Merzon RM; Villegas J
Glia; 1990; 3(5):393-404. PubMed ID: 1699892
[TBL] [Abstract][Full Text] [Related]
15. Tachykinin activation of human monocytes from patients with interstitial lung disease, healthy smokers or healthy volunteers.
Brunelleschi S; Nicali R; Lavagno L; Viano I; Pozzi E; Gagliardi L; Ghio P; Albera C
Neuropeptides; 2000 Feb; 34(1):45-50. PubMed ID: 10688968
[TBL] [Abstract][Full Text] [Related]
16. Neurobiology of substance P and the NK1 receptor.
Mantyh PW
J Clin Psychiatry; 2002; 63 Suppl 11():6-10. PubMed ID: 12562137
[TBL] [Abstract][Full Text] [Related]
17. Neurokinin-induced salivation in the anesthetized rat: a three receptor hypothesis.
Murray CW; Cowan A; Wright DL; Vaught JL; Jacoby HI
J Pharmacol Exp Ther; 1987 Aug; 242(2):500-6. PubMed ID: 3039119
[TBL] [Abstract][Full Text] [Related]
18. Oxytocin release from the rat neurohypophysis into the blood: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M; Boczek-Leszczyk E
J Physiol Pharmacol; 2008 Sep; 59(3):553-62. PubMed ID: 18953097
[TBL] [Abstract][Full Text] [Related]
19. Tachykinin receptors of the NK1 type (substance P) coupled positively to phospholipase C on cortical astrocytes from the newborn mouse in primary culture.
Torrens Y; Daguet De Montety MC; el Etr M; Beaujouan JC; Glowinski J
J Neurochem; 1989 Jun; 52(6):1913-8. PubMed ID: 2470856
[TBL] [Abstract][Full Text] [Related]
20. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
